Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00344058 · ClinicalTrials.gov registry record · NA
Abbreviated MgSO4 Therapy in Post-partum Preeclampsia
A NA study, sponsored by Case Western Reserve University.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT00344058 is a NA study that has completed, run by Case Western Reserve University. The registered enrollment target is 200 participants.
The verdict
NCT00344058, a NA study, has completed, sponsored by Case Western Reserve University.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
Magnesium sulfate is used for seizure prophylaxis in pregnancies complicated by preeclampsia. There is debate as to how long to continue this therapy after delivery of the pregnancy. Different schemes have been offered to shorten the exposure to magnesium sulfate after delivery, with little data. We seek to investigate the effect of shortened magnesium sulfate therapy on the post-partum recovery phase of mild preeclampsia. Our hypothesis was that shortened therapy (12 hours versus the traditional 24 hours post-partum) has no effect on disease course, and will result in significantly shorter exposure to magnesium sulfate.
Interventions
- DRUG abbreviation of magnesium sulfate therapy (12 hours versus the traditional 24 hours after delivery)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2001-01 |
| Est. Completion | 2004-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00344058
The ClinicalTrials.gov registry entry for NCT00344058 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Western Reserve University, which has 141 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which abbreviation of magnesium sulfate therapy (12 hours versus the traditional 24 hours after delivery) is the first listed.
NCT00344058 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00344058 about?
NCT00344058 is a clinical study titled "Abbreviated MgSO4 Therapy in Post-partum Preeclampsia". Magnesium sulfate is used for seizure prophylaxis in pregnancies complicated by preeclampsia. There is debate as to how long to continue this therapy after delivery of the pregnancy. Different schemes have been offered to shorten the exposure to magnesium sulfate after delivery, with little data. We...
What is the current status of trial NCT00344058?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2001-01. Estimated completion is 2004-08.
What interventions are being tested in trial NCT00344058?
The interventions under investigation include: abbreviation of magnesium sulfate therapy (12 hours versus the traditional 24 hours after delivery) (DRUG).
Who is sponsoring clinical trial NCT00344058?
This trial is sponsored by Case Western Reserve University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.